AllianceBernstein
AURA icon

AllianceBernstein’s Aura Biosciences AURA Stock Holding History

AllianceBernstein’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$227K Hold
41,660
– – ﹤0.01% 2996
2025
Q4 		$227K Hold
41,660
– – ﹤0.01% 3016
2025
Q3 		$257K Hold
41,660
– – ﹤0.01% 2994
2025
Q2 		$261K Buy
41,660
+17,840
+75% +$104K ﹤0.01% 2982
2025
Q1 		$140K Hold
23,820
– – ﹤0.01% 3013
2024
Q4 		$196K Hold
23,820
– – ﹤0.01% 3027
2024
Q3 		$212K Buy
23,820
+1,450
+6% +$12.4K ﹤0.01% 3024
2024
Q2 		$169K Buy
22,370
+9,440
+73% +$69.1K ﹤0.01% 3059
2024
Q1 		$102K Hold
12,930
– – ﹤0.01% 3029
2023
Q4 		$115K Buy
12,930
+2,230
+21% +$18.9K ﹤0.01% 3055
2023
Q3 		$96K Buy
10,700
+570
+6% +$6.13K ﹤0.01% 3075
2023
Q2 		$125K Buy
+10,130
New +$108K ﹤0.01% 3058

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AllianceBernstein's AURA Position: Q1 2026 in Review

AllianceBernstein held its Aura Biosciences (AURA) position steady in Q1 2026 at 41,660 shares worth $227K. The position accounts for ﹤0.01% of the portfolio, ranked #2996.

AllianceBernstein first reported a position in AURA in Q2 2023 and has held it in 12 quarters since. The position peaked at $261K in Q2 2025. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • AllianceBernstein held 41,660 shares of Aura Biosciences worth $227K as of Q1 2026.
  • AllianceBernstein left its Aura Biosciences share count unchanged in Q1 2026.
  • Aura Biosciences made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2996 holding.
  • AllianceBernstein first reported a position in Aura Biosciences in Q2 2023 and has held it in 12 quarters since.
  • AllianceBernstein's Aura Biosciences position peaked at $261K in Q2 2025.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.